Cost-Savings for Capecitabine Due to Oral Administration in Previously Untreated Advanced/Metastatic Colorectal Cancer (English)
- New search for: Hieke, K.
- New search for: Twelves, C.
- New search for: Boyer, M.
- New search for: Findlay, M.
- New search for: Weitzel, C.
- New search for: Barker, C.
- New search for: Osterwalder, B.
- New search for: Jamieson, C.
- New search for: Hieke, K.
- New search for: Twelves, C.
- New search for: Boyer, M.
- New search for: Findlay, M.
- New search for: Weitzel, C.
- New search for: Barker, C.
- New search for: Osterwalder, B.
- New search for: Jamieson, C.
In:
VALUE IN HEALTH
;
3
, 5
;
306
;
2000
-
ISSN:
- Article (Journal) / Print
-
Title:Cost-Savings for Capecitabine Due to Oral Administration in Previously Untreated Advanced/Metastatic Colorectal Cancer
-
Contributors:Hieke, K. ( author ) / Twelves, C. ( author ) / Boyer, M. ( author ) / Findlay, M. ( author ) / Weitzel, C. ( author ) / Barker, C. ( author ) / Osterwalder, B. ( author ) / Jamieson, C. ( author )
-
Published in:VALUE IN HEALTH ; 3, 5 ; 306
-
Publisher:
- New search for: VALUE IN HEALTH
-
Publication date:2000-01-01
-
Size:306 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 3, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 295
-
Is Quality of Life a Valid Outcome for Varicose Veins Surgery? Results of an International Epidemiological StudyKurz, X. / Lamping, D. L. / Kahn, S. R. / Abenhaim, L. / VEINES Study Group et al. | 2000
- 295
-
Effectiveness and Cost-Effectiveness of Eptifibatide in Individual Patients with Acute Cardiac Ischemia: The Importance of Risk StratificationKent, D. M. / Ruthazer, R. / Beshansky, J. R. / Selker, H. P. et al. | 2000
- 296
-
Modelling the Costs and Effects of CMV Management Strategies in Transplant Recipients as a Support for Current and Future Decision-MakingAnnemans, L. / Moeremans, K. / Kubin, M. et al. | 2000
- 296
-
Impact of Carvedilol on Inpatient Resource Use and Costs in Heart FailureVera-Llonch, M. / Oster, G. / Lukas, M. / Fowler, M. / US. Carvedilol Heart Failure Study Group et al. | 2000
- 296
-
Cost-Effectiveness Analysis of Hexavalent Meningococcal B Outer-Membrane-Vesicle VaccineBos, J. M. / Rumke, H. C. / Welte, R. / Postma, M. J. / Jager, J. C. et al. | 2000
- 297
-
Preliminary Evaluation of the Clinical and Economic Benefits of Universal Varicella Vaccination of Children in GermanyBanz, K. / Staginnus, U. / Wagenpfeil, S. / Neiss, A. / Goertz, A. / Bisanz, H. / Wutzler, P. et al. | 2000
- 297
-
Avoidable Hospitalization: Trends and Ethnic Variations in Singapore, 1991-1998Ng, T. P. / Niti, M. P. et al. | 2000
- 298
-
A New Index Approach to Measure the Benefits of Delaying the Progression to BlindnessAlthin, R. / Roos, P. et al. | 2000
- 298
-
Measuring Reduced Productivity during Paid LaborRothermich, E. A. / Pathak, D. S. et al. | 2000
- 298
-
The Influence of Non-Cardiac Vascular Disease on the Cost-Effectiveness of Screening for Left Ventricular Systolic Dysfunction (LVSD)Davey, P. G. / Kelly, R. / Tunstall Pedoe, H. / Struthers, A. et al. | 2000
- 299
-
A Multicenter Study of Pharmacist Directed Interventions in Dyslipidemia TherapyReeg-Dhingra, M. P. / Howard, P. A. / Fincham, J. E. et al. | 2000
- 299
-
An Economic Evaluation of Tinzaparin Compared to Standard Heparin in Treating Pulmonary EmbolismAnnemans, L. / Robays, H. / Rasmussen, J. A. / Lewis, D. N. / Kestens, D. G. et al. | 2000
- 300
-
Generic and Disease-Specific Health Related Quality of Life Measurements in 127 Rheumatoid Arthritis 167 Osteoarthritis Patients in HungarySzende, A. / Balint, G. / Lovas, K. / Hodinka, L. / Szebenyi, B. / Hejj, G. et al. | 2000
- 300
-
Quality of Life after Osteoporotic Fractures in Dutch Men and WomenDe Laet, C. E. / van Busschbach, J. / van der Klift, M. / Lips, P. / Pols, H. A. / Dutch Osteoporosis Consensus Committee et al. | 2000
- 300
-
Impact of Post-Fracture Treatment Costs and Model Time Horizon on Cost-Effectiveness of Osteoporosis TherapiesGrima, D. T. / Becker, D. L. / Burge, R. T. et al. | 2000
- 301
-
An Investigation of Factors Used by Patients for Drug Treatment Decision-Making: An Examination of Therapy Options for Erectile DysfunctionJackson-Kline, S. E. et al. | 2000
- 301
-
Development and Validation of a Treatment Satisfaction Module for Use with Menopausal WomenMcLaughlin-Miley, C. / Abetz, L. / Plante, M. / Vallow, S. / Gash, D. / Arbit, D. et al. | 2000
- 302
-
Comparison of Imputation Methods for Missing Asthma Quality of Life DataRunken, M. C. / Bramley, T. J. / Eaddy, M. T. / Schulz, R. M. et al. | 2000
- 302
-
The Valuation of Disease-Specific Health States to Facilitate Economic Evaluation of PharmaceuticalsKok, E. / Stolk, E. / van Busschbach, J. et al. | 2000
- 303
-
Quality of Life of Asthmatic Patients with Different Severity of DiseaseSvensson, K. / Szende, A. / Meszaros, A. / Berta, G. Y. / Stahl, E. et al. | 2000
- 303
-
Symptom-Based Outcome Measures for AsthmaMcKenzie, L. / Cairns, J. / Osman, L. et al. | 2000
- 303
-
Two-Part Models for Demand of Hospital Treatment in Type II Diabetic PatientsWang, J. S. / Steinke, D. / Davey, P. / Morris, A. et al. | 2000
- 304
-
Aggregation of Willingness-To-Pay Measured in Decomposed ScenariosKlose, T. / Zeitler, H. P. / Leidl, R. et al. | 2000
- 304
-
The Willingness to Pay for Reduced Urge IncontinenceCapri, S. / Sormani, M. P. / Lavezzari, M. / Velona, T. et al. | 2000
- 304
-
A Five Year Longitudinal Analysis of the Health Benefits of Transitioning to Insulin Therapy Sooner in the Management of Newly Diagnosed Type II DiabeticsSimons, W. R. / Kemp, R. / Bolinder, B. et al. | 2000
- 305
-
Health Care Workers' Perceptions on Health Status after Renal Transplantation: A Comparison with Transplantation Candidates' ExpectationsCleemput, I. / Kesteloot, K. / De Geest, S. / Van Pelt, A. / Vlaminck, H. / Geuens, M. / Vanrenterghem, Y. et al. | 2000
- 305
-
Eradication of Helicobacter Pylori to Prevent Peptic Ulcers Prior to Nsaid Therapy-A Cost-Effectiveness AnalysisYou, J. H. / Lee, K. K. / Chan, F. K. / Sung, J. J. / Yung, M. Y. / Chung, S. S. et al. | 2000
- 306
-
Cost-Effectiveness Analysis of Irinotecan as First-Line Therapy in Advanced Colorectal CancerSchmitt, C. / Levy-Piedbois, C. / Frappe, M. / Durand-Zaleski, I. et al. | 2000
- 306
-
Relating Quality Adjusted Life Years to Contingent Valuation: Acute Versus Chronic IllnessesFranic, D. M. / Pathak, D. S. / Schweikhart, S. B. / Dasta, J. et al. | 2000
- 306
-
Cost-Savings for Capecitabine Due to Oral Administration in Previously Untreated Advanced/Metastatic Colorectal CancerHieke, K. / Twelves, C. / Boyer, M. / Findlay, M. / Weitzel, C. / Barker, C. / Osterwalder, B. / Jamieson, C. et al. | 2000
- 307
-
Atypical Antipsychotics and the Risk of Developing DiabetesCaro, J. / Ward, A. / Levinton, C. / Robinson, K. et al. | 2000
- 307
-
Patterns of Use of Antidepressant and Concomitant PsychotropicsFulop, G. / Bona, J. / Brookler, R. / Nemeroff, C. et al. | 2000
- 308
-
Patients' Reported Health Status and Utilities for Amyotrophic Lateral SclerosisGreen, C. / Kiebert, G. M. / Murphy, C. / Leigh, P. N. / Mitchell, J. D. / Burrell, A. et al. | 2000
- 308
-
Validation of a Methodology for Estimating Productivity Gains from Improvements in Ham-D ScoresSchonfeld, W. H. / Sheriff, S. K. et al. | 2000
- 309
-
Economic Evaluation of Transdermal Fentanyl in the Treatment of Chronic Non-Cancer Pain in DenmarkFrei, A. / Nuyts, G. / Mehnert, A. / Gerber, D. et al. | 2000
- 309
-
Quality of Life After Subarachnoid Hemorrhage in Relation to Risk Estimation Before SurgeryToth, K. J. / Szende, A. / Contreras, M. / Nyary, I. / Futo, J. et al. | 2000
- 309
-
The Atrial Fibrillation Antithrombosis Model (AFAM): A General-Purpose Tool for Analysis, Policy-Making, and EducationMatchar, D. / Samsa, G. / Sonnenberg, F. / Hagerty, G. et al. | 2000
- 310
-
Population Projections of Cardiovascular Disease Morbidity and Mortality Associated with Rofecoxib's Effect on Systolic Blood PressureRussell, M. W. / Miller, J. D. / Taylor, D. C. / Huse, D. M. et al. | 2000
- 310
-
The Cost-Effectiveness of Treating Chlamydia Pneumoniae Infection for the Prevention of Coronary Heart DiseaseSanderson, C. / Kubin, M. et al. | 2000
- 311
-
Cost-Effectiveness of Doxazosin in Combination Therapy for Hypertension Treatment in Diabetic Patients in the UKCasciano, J. / Doyle, J. / Casciano, R. / Kopp, S. / Arikian, S. / Marchant, N. / Kim, R. et al. | 2000
- 311
-
Economic Evaluation of Ramipril in the Treatment of Patients at High Risk of Cardiovascular EventsBackhouse, M. E. / Richer, A. / Gaffney, L. et al. | 2000
- 311
-
Gender Differences in the Quality of Life and Compliance with Routine Treatment of Essential Hypertensives in an Economically Disadvantaged CommunityGolubev, S. A. / Miliy, M. N. et al. | 2000
- 312
-
Incremental Cost-Effectiveness Ratio in Estimation some Hypotensive DrugsFrisman, M. / Geltzer, B. et al. | 2000
- 312
-
Hospitalization Costs after First Acute Coronary Syndrome: A Combined Model ApproachWang, J. / Donnan, P. T. / Morris, A. D. et al. | 2000
- 313
-
Retrospective Medical Record Review to Determine the "At Goal" Patients with Hypertension and/or DyslipidemiaGunnarsson, P. / Livengood, K. / Lytken Larsen, M. / Pettersson, S. / Claeys, M. J. / Norstrom, F. / Saldeen Nilehn, K. / Beys, J. et al. | 2000
- 313
-
Prophylaxis Against Deep-Vein Thrombosis and Fatal Pulmonary Embolism in Knee Arthroplasties: A Cost-Effectiveness StudyNerurkar, J. / Wade, W. E. / Martin, B. C. et al. | 2000
- 313
-
Determinants of Costs and Resource Utilization Associated with Open Heart SurgerySokolovic, E. / Schmidlin, D. / Schmid, E. / Ruef, C. / Szucs, T. et al. | 2000
- 314
-
Costs Associated with Health Services Utilization in Patients with Varicose VeinsKurz, X. / Durand-Zaleski, A. L. / VEINES Study Group et al. | 2000
- 314
-
A Cost Comparison Study of Amlodipine and Enalapril in the Treatment of Hypertension in EuropeDoyle, J. / Arikian, S. / Casciano, J. / Casciano, R. / Gonzalez, M. / Kopp, Z. et al. | 2000
- 315
-
Using the General Practice Research Database to Generate an "At Risk Register" for a Primary Care Stroke Prevention ProgramChapman, S. R. / Heatlie, H. F. / Frischer, M. / Bashford, J. et al. | 2000
- 315
-
Anti-Hypertensive Agents and the Risk of Hip or Wrist Fractures in an Otherwise Healthy Community PopulationLaer, C. / LeLorier, J. et al. | 2000
- 315
-
Cost-Effectiveness of Low-Molecular Weight Heparin Versus Oral Anticoagulants for Secondary Prophylaxis of Venous ThromboembolismMarchetti, M. / Pistorio, A. / Barosi, G. et al. | 2000
- 316
-
Variability in Abciximab (REOPRO®) Usage: Evidence-Based or Budget-Driven?Zwart-van Rijkom, J. / Leufkens, H. / Broekmans, A. et al. | 2000
- 316
-
Cost-Effectiveness of Prevention of Atherothrombotic Disease with Aspirin Versus Clopidogrel in GreeceGeitona, M. / Kyriopoulos, J. / Geitonas, C. / Papademetriou, A. / Nikolaou, V. et al. | 2000
- 317
-
Turkish Physician Prescription Patterns for Hypertension ManagementSapci, H. / Bozkurt, E. / Durlu, T. / Kandilci, B. / Ozsogut, B. / Demirdamar, R. et al. | 2000
- 317
-
Variation in Medical Resource Utilization in the Management of Pulmonary EmbolismAnnemans, L. / Robays, H. et al. | 2000
- 317
-
Annual Cost of Treating Hyperlipidemia in a Managed Care PopulationShahriar, J. / McLaughlin, T. / Margraf, T. et al. | 2000
- 318
-
Cost-Effectiveness of HMG-CoA Reductase Inhibitors and Fibrates Therapy in Elderly Women with Coronary Artery DiseaseLazebnik, L. B. / Kadiskaya, M. J. et al. | 2000
- 318
-
Variation in Costs of Treating Hypercholesterolemic Patients in FranceSmith, D. et al. | 2000
- 318
-
The Cost of Reaching LDL-C Targets in Spain: A Comparison Among StatinsSmith, D. et al. | 2000
- 319
-
Cost of Care and Blood Pressure Control in Hypertensive Patients in Emilia Romagna Region (Italy): Results from the GREAT StudyAmbrosioni, E. / Belisari, A. / Bustacchini, S. / Costa, F. V. / Greco, S. / Ruffo, P. / Tinelli, M. / Mantovani, L. G. / GREAT investigators et al. | 2000
- 319
-
The Cost of Stroke in Greece In 1998Kyriopoulos, J. / Geitona, M. / Karamalis, E. et al. | 2000
- 320
-
Treatment of Chronic Heart Failure (CHF): Improving Survival but Not Health-Related Quality of Life (HRQL)Chassany, O. / Mahe, I. / Duracinsky, M. et al. | 2000
- 320
-
Savings Achieved in an HMO Sponsored Primary Care based Disease Management and Case Management InitiativeFisher, F. J. / Sidorov, J. / Fox, G. / Girolami, S. / Dobeck, L. / Donmoyer, C. / Riehl, P. / Shull, R. / Wolke, O. et al. | 2000
- 320
-
Supporting Implementation of Prescription Guidelines in Medical Wards: A Randomized TrialFontaine, A. / Vinceneux, P. / Fiessinger, J. N. / Bergmann, J. F. / Dhote, R. / Cohen, P. et al. | 2000
- 321
-
Associated Outcomes of Influenza-Like-Illness and Clinical Influenza in ItalyCosta, B. / Arpinelli, F. / Bamfi, F. et al. | 2000
- 321
-
Cost-Effectiveness of Hepatitis B Vaccination in The NetherlandsDe Wit, G. A. / Kretzschmar, M. E. / Struijs, J. N. / Smits, L. J. / Postma, M. J. / van de Laar, M. J. / Jager, J. C. et al. | 2000
- 321
-
Phamacoeconomic Evaluation of Immunoprophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk InfantsDoshi, J. / Kamal-Bahl, S. et al. | 2000
- 322
-
Medico-Economic Modelling of Influenza Management in Europe: Methodology Used in France and GermanyMegas, F. / Baron, F. / Kilburg, A. / Rychlik, R. / Scuffham, P. / Piercy, J. et al. | 2000
- 322
-
Hospital Antibiotics Utilization EvaluationCaicoya, M. / Natal, C. et al. | 2000
- 323
-
Canadian Cost-Effectiveness of Combination Ribavirin/Interferon Alpha-2b Therapy for Treatment-Naive Viral Hepatitis CMarotta, P. J. / Wong, W. / Wong, J. B. et al. | 2000
- 323
-
Multitherapies: Towards Cost-Saving Strategies in Real Life?Le Pen, C. / Rozenbaum, W. / Downs, A. / Lilliu, H. / Maurel, F. / Brun, C. et al. | 2000
- 324
-
Cost-Effectiveness of Ciprofloxacin + Hydrocortison Versus Neomycin + Polymixin + Hydrocortison in the Treatment of Acute Otitis ExternaLafuma, A. / Fagnani, F. / Berdeaux, G. et al. | 2000
- 324
-
Cost-Effectiveness Analysis of Antibiotic Prophylaxis in Intra-Abdominal SurgeryRozenson, O. / Stratchounski, L. et al. | 2000
- 324
-
Patients' Compliance and Cost-Effectiveness of Selected Oral Antibacterials in Inpatient Treatment of Skin and Soft Tissue InfectionsSchadlich, P. K. / Brecht, J. G. / Frank, U. / Huppertz, E. et al. | 2000
- 325
-
The Impact of Price Elasticity of Demand on Consumption-Ampicillin/Amoxicillin Market Survey in Bulgaria, 1995 and 1999Borissov, B. / Popova, M. / Koulaksazova, R. et al. | 2000
- 325
-
The Peace Project (Prescription and Effectiveness of Antibiotic in Clinical Experience): Results of the Feasibility StudyDegli Esposti, L. / Valpiani, G. / De Portu, S. / Ceccarelli, P. L. / Sturani, A. / Cocchi, R. / Degli Esposti, E. et al. | 2000
- 326
-
Cost-Effectiveness of Ganciclovir in Prevention of Cytomegalovirus Disease after Liver Transplantation: A Bayesian ApproachVanness, D. J. / Kim, W. R. et al. | 2000
- 326
-
To Compare and Contrast the Quality of Life (QoL) of Individuals with Chronic Bronchitis, during the Stable Phase and Acute ExacerbationsWild, D. / Grey Amante, P. / Doll, H. / Duprat-Lomon, I. / Mast, O. / Sagnier, P. P. / Thate-Waschke, I. M. et al. | 2000
- 326
-
Modeling Physician Preferences in Antibiotic ChoiceMorris, M. S. / Sokol, W. / Singh, A. / Ashraf, T. et al. | 2000
- 327
-
Cost-Effectiveness Analysis of Basic and Immunotropic Therapy in Children with Bronchial AsthmaProsekova, E. / Geltzer, B. / Bogdanovskiy, P. / Markelova, E. et al. | 2000
- 327
-
EuroQol EQ-5D: Discriminant Validity in Respiratory DiseaseLaybourn, M. / Cropper, J. / Frank, T. / Frank, P. et al. | 2000
- 328
-
A Health Economic Model to Describe the Current and Expected Burden of COPDAnnemans, L. / Lamotte, M. / Keech, M. / Wilson, K. et al. | 2000
- 328
-
Cost-Effectiveness of Emedastine Versus Levocabastine in the Treatment of Allergic ConjunctivitisGouveia Pinto, C. / Lafuma, A. / Fagnani, F. / Berdeaux, G. et al. | 2000
- 328
-
Quality of Life and Treatment Satisfaction Measurement with Asthma Patients: Results from a Comprehensive Literature ReviewAbetz, L. N. / Jones, M. K. / Adesina, K. / Emery, M. P. et al. | 2000
- 329
-
Treatment and Associated Costs of Newly Diagnosed COPD Patients in a Managed Care PopulationCox, F. / Ramaswamy, K. / Okamoto, L. / McLaughlin, T. et al. | 2000
- 329
-
An Economic Impact of a DUR Intervention on the Pharmacological Management of Asthma in ChildrenRaut, M. K. / Stuart, B. / Zuckerman, I. H. et al. | 2000
- 330
-
Age and Gender Differences in Utilization of Asthma Medication in Children and Young Adults in Tayside, ScotlandMcNaughton, D. M. / Libby, G. / Donnan, P. T. / MacDonald, T. M. et al. | 2000
- 330
-
Impact of Bronchial Asthma on Child's Quality of LifeProsekova, E. / Geltzer, B. / Shestovskaya, T. et al. | 2000
- 330
-
Problematic Issues of the Quality of Asthma Management in Rural Areas in GreeceKarokis, A. / Lionis, C. / Daraki, V. / Rovithis, E. / Siafakas, N. et al. | 2000
- 331
-
Asthma and Anti-Asthma Drug Use in HungaryMeszaros, A. / Zoltan, V. / Galik, E. et al. | 2000
- 331
-
Cost of Illness on Patients in a Public Hospital with Severe Exacerbation of Chronic Obstructive Airway DiseaseLee, K. K. / Tam, K. Y. / Leung, S. M. / You, J. H. / Chan, T. Y. et al. | 2000
- 331
-
Annual Cost of Treating Rhinitis in a Managed Care PopulationBataoel, J. / McLaughlin, T. / Margraf, T. et al. | 2000
- 332
-
Outcomes Research Study Assessing Resource Utilization for the Treatment of Asthma Exacerbation in Primary Care in SpainKielhorn, A. / Molina, J. / Naberan, K. / Alonso, J. A. / Price, K. et al. | 2000
- 332
-
Economic Impact of the Respiratory Syncytial Virus Disease, French Societal PerspectiveLevy, E. / Aymard, M. / Smadja, C. / Bouveret Le Cam, N. / Taieb, C. et al. | 2000
- 333
-
Epidemiology and Costs of Bronchial Asthma and Chronic Bronchitis in GermanyWeissflog, D. et al. | 2000
- 333
-
Cost-Effectiveness Analysis of NSAIDs vs COX-2 Specific Inhibitors and NSAIDs with Co-Treatments to Prevent GI Toxicity in the Treatment of RAYun, H. R. / Corzillius, M. / Kim, S. Y. / Bae, S. C. et al. | 2000
- 333
-
Use of Pharmacotherapy as an Asthma Severity Measure in a Retrospective AnalysisBataoel, J. / McLaughlin, T. / Margraf, T. et al. | 2000
- 334
-
Direct Medical Cost of Chronic Polyarthritis in GermanyBerger, K. / Ehlken, B. / Smala, A. / Thurmel, K. / Wegmann, T. / Schattenkirchner, M. et al. | 2000
- 334
-
A Cost-Cost Study Comparing Etanercept with Infliximab in Moderate to Severe Rheumatoid ArthritisNuijten, M. J. / Engelfriet, P. M. / Duijn, K. J. / Wierz, D. / Koopmanschap, M. et al. | 2000
- 335
-
The Costs of Rheumatoid Arthritis: Is There a Need for Standardization of Methods?Barbieri, M. / Drummond, M. et al. | 2000
- 335
-
COX-II Inhibitors and NSAIDs: Findings of a Nice SubmissionDickson, A. J. et al. | 2000
- 335
-
Budgetary Impact Analysis for use in Reimbursement Process of Etanercept in Moderate to Severe Rheumatoid ArthritisNuijten, M. J. / Engelfriet, P. M. / Duijn, K. J. / Wierz, D. / Kiebert, G. et al. | 2000
- 336
-
Hospital Costs, Days, and Post-Acute Care for Vertebral Fractures in WomenBurge, R. T. / Worley, D. et al. | 2000
- 336
-
Cost-of-Illness Studies in Germany with Osteoporosis as ExampleBrecht, J. G. / Schadlich, P. K. et al. | 2000
- 337
-
Variations in Medication Utilization in an Older Diabetic PopulationAnderson, R. T. / Balkrishnan, R. / Sevick, M. A. / Camacho, F. T. / Byerly, W. G. et al. | 2000
- 337
-
Annual Cost of Treating Carpal Tunnel Syndrome in a Managed Care PopulationRigoni, G. / McLaughlin, T. / Margraf, T. et al. | 2000
- 337
-
Is Residronate More Cost-Effective than Etidronate for Fracture Prevention? A Cost-Utility AnalysisIglesias, C. / Torgerson, D. et al. | 2000
- 338
-
Use of Bootstrap in a Cost-of-Illness Study to Derive Accuracy of EstimatesWagenpfeil, S. / Stammer, H. / Neiss, A. / Reitberger, U. / Goertz, A. et al. | 2000
- 338
-
Cost-Effectiveness of a New Human Dermal Replacement for the Treatment of Diabetic Foot Ulcers: The Case of FranceParee, F. / Allenet, B. / Possnett, J. / Carr, L. et al. | 2000
- 339
-
Effect of a Policy Change on Use of Blood Glucose Monitors By Diabetics with Medicare CoverageSilverman, B. G. et al. | 2000
- 339
-
The Economic Burden of Type 2 Diabetes on the IndividualHolmes, J. / Bottomley, J. / Gillam, S. / Murphy, M. et al. | 2000
- 339
-
The Financial Effects of Interface Agreements for Diabetes Mellitus: Socioeconomic Relevance of Intensive Controlled Insulin Therapy with Insulin Lispro Compared to Regular Human InsulinKilburg, A. / Clouth, J. / Daniel, D. / Kirchoff, D. / Rychlik, R. et al. | 2000
- 340
-
Health Related Quality of Life in Type 2 DiabetesHolmes, J. / Bottomley, J. / Gillam, S. / Murphy, M. et al. | 2000
- 340
-
Alopecia, Psychological Distress and Quality of LifeTaieb, C. / Smadja, C. et al. | 2000
- 341
-
Pharmacoeconomic Modeling in Assisted Reproduction Technologies: Recombinant FSH Versus Urinary FSHAuray, J. P. / Duru, G. / Daya, S. / Ledger, W. / Silverberg, K. / Wikland, M. / Bouzayen, R. / Howles, C. / Beresniak, A. et al. | 2000
- 341
-
Presentation of the 23-Item Women's Health Questionnaire (WHQ): Scoring and Interpretation IssuesGirod, I. / Keininger, D. L. / de la Loge, C. / Hunter, M. et al. | 2000
- 341
-
An Assessment of the Relation Between Sildenafil Use and Quality of Life DimensionsGasper, S. / Macdonald, K. et al. | 2000
- 342
-
Methodological Issues in Evaluating Conceptual Equivalence: Application to the Women's Health Questionnaire (WHQ)Girod, I. / Keininger, D. L. / de la Loge, C. / Hunter, M. et al. | 2000
- 342
-
Appraisal of Erectile Dysfunction: Whose Values Should Be Used?Stolk, E. / Busschbach, J. et al. | 2000
- 343
-
Issues in Using Conjoint Analysis to Value Health Care Within Clinical StudiesGirod, I. / Marquis, P. et al. | 2000
- 343
-
The Impact of Dementia on the Quality of Life of Caregivers of Elderly PeopleScuvee-Moreau, J. / Kurz, X. / Dresse, A. et al. | 2000
- 343
-
Economic Assessment of the Direct Specific Cost of Benign Prostatic Hyperplasia in France, Health Insurance PerspectiveChopin, D. / Smadja, C. / Taieb, C. et al. | 2000
- 344
-
Global Index of Safety (GIS): A New Instrument to Assess Drug Safety: Application to a Prospective Pharmacoepidemiological Study (EFESO)Sacristan, J. A. / Gomez, J. C. / Badia, X. / Kind, P. / Gavart, S. / EFESO Study Group et al. | 2000
- 344
-
Evaluation of the CES-D in Six Countries Using Rasch Item Response Theory (IRT) AnalysisBushnell, D. M. / Whalley, D. et al. | 2000
- 345
-
Antipsychotic Treatment, Adverse Events and Health-Related Quality of LifeBadia, X. / Casado, A. / Sacristan, J. A. / Gomez, J. C. / Gregor, K. J. / Gavart, S. / EFESO Study Group et al. | 2000
- 345
-
Clinical, Humanistic, and Economic Outcomes Associated with Long-Term Treatment of Mania with OlanzapineNamjoshi, M. / Edgell, E. T. / Feldman, P. D. / Sanger, T. M. / Tohen, M. F. / Breier, A. et al. | 2000
- 345
-
Impact of Amisulpride on Health Care Resources in Schizophrenia: Preliminary Results of a French StudyLevy, E. / Olie, J. P. / Spiesser, J. et al. | 2000
- 346
-
Pharmacoeconomic Modelling in Depression: Aid or TrapToumi, M. / Francois, C. / Hansen, K. et al. | 2000
- 346
-
Treatment Patterns of Patients with Schizophrenia and Schizo-Affective Disorder Across 15 CountriesPatel, A. / Knapp, M. / Beecham, J. et al. | 2000
- 346
-
Subjective Response to Antipsychotic Treatment and Compliance in SchizophreniaGarcia-Cabeza, I. / Gomez, J. C. / Sacristan, J. A. / Edgell, E. T. / Gonzalez de Chavez, M. / Gavart, S. / EFESO Study Group et al. | 2000
- 347
-
Deinstitutionalization Model in Schizophrenia: Cost-Consequences of Intensive Case Management Versus Standard Case ManagementLlorca, P. M. / Toumi, M. / Francois, C. / Hansen, K. / Lancon, C. et al. | 2000
- 347
-
Data Triangulation in the Assessment of Substance Abuse Treatment Outcomes in Adolescent PopulationsCiesla, J. / Spear, S. et al. | 2000
- 348
-
The Medical Costs of Dementia in Belgium: Results of the NADES StudyScuvee-Moreau, J. / Kurz, X. / Dresse, A. et al. | 2000
- 348
-
Cost of Care in Schizophrenia Patients-Results from the National Outcomes Measurement Study in SchizophreniaAtkinson, M. A. / Kopala, L. C. / Malla, A. K. / Smith, G. / Williams, R. et al. | 2000
- 349
-
Relapse in Schizophrenia: Costs and Quality of LifeBrugha, T. / Almond, S. / Francois, C. / Toumi, M. et al. | 2000
- 349
-
Economic Evaluation of Reboxetine for Treating Major DepressionSheriff, S. K. / Levaux, H. P. / Villa, K. F. / Schonfeld, W. H. / Rowland, C. / Williamson, T. E. et al. | 2000
- 349
-
Cost of Treating Side Effects of Selective Serotonin Re-Uptake Inhibitors (SSRIs) in a Health Maintenance Organization (HMO)Rascati, K. L. et al. | 2000
- 350
-
Pamidronate for Breast Cancer Patients with Skeletal Metastases: A Markov Tree-Based Cost-Utility AnalysisLiberato, N. L. / Marchetti, M. / Tamburlini, A. / Barosi, G. et al. | 2000
- 350
-
The Level of Haemoglobin (Hb) in U.K. Cancer Patients Correlates Positively with Quality of Life (QoL)Lind, M. / Littlewood, T. / Vernon, C. / Wilkinson, P. / Cruickshank, D. / Stuart, N. / Jenkinson, C. / Grey-Amante, P. / Wild, D. et al. | 2000
- 351
-
Economic Consequences of Differences in the Adverse-Events (AE) Profile of Capecitabine vs. Mayo Clinic (M) -Regimen in Previously Untreated Advanced/Metastatic Colorectal CancerHieke, K. / Twelves, C. / Boyer, M. / Findlay, M. / Weitzel, C. / Barker, C. / Osterwalder, B. / Jamieson, C. et al. | 2000
- 351
-
Comparison of Costs and Effects of Prophylactic Pamidronate for the Prevention of Skeletal Related Events in Patients with Advanced Breast Cancer in Poland (Cost-Effectiveness and Cost-Utility Analysis)Orlewska, E. et al. | 2000
- 352
-
Evaluation of Three Different Methods of Assessing Willingness to Pay for a New Drug in the General PopulationBadia, X. / Pinto, J. / Magaz, S. et al. | 2000
- 352
-
Quality of Life Assessment of Docetaxel Treated Patients in Advanced Breast CancerPoddubnaya, I. V. / Arkadyeva, T. V. / Davydenko, I. S. / Komarova, V. P. et al. | 2000
- 352
-
Family Caregiving Costs for the Elderly with Cancer: Estimates from a Representative Sample of the United StatesLanga, K. / Hayman, J. / Kabeto, M. / Chernew, M. / Katz, S. / Slavin, M. / Fendrick, A. M. et al. | 2000
- 353
-
An Approach to Designing a Multi-National Model for the Current Treatment of Breast CancerNoe, L. N. / Becker, R. V. / Gore, M. / Martino, S. / Eiermann, W. / Namer, M. / Howell, A. / Bianco, A. R. / Watanabe, T. / Chen, D. M. et al. | 2000
- 353
-
Cost-Utility Analysis of Several Second-Line Chemotherapy Schemes for Patients with Metastatic Breast CancerUyl-de Groot, C. A. / Li, N. / van Agthoven, M. / Willemse, P. et al. | 2000
- 354
-
Comparison of Costs and Effects of Prophylactic Clodronate for the Prevention of Skeletal Related Events in Patients with Advanced Breast Cancer in PolandOrlewska, E. et al. | 2000
- 354
-
Changes in Outpatient Drug Costs for Cancer Patients, 1995 vs 1998Halbert, R. J. / Zaher, C. / Wade, S. / Malin, J. / Dubois, R. W. / Lawless, G. et al. | 2000
- 354
-
Payer Costs of Pancreatic Cancer in a Nonelderly Medicaid PopulationMalkin, J. D. / Pelletier, E. M. / Van Gool, R. / Goss, T. F. et al. | 2000
- 355
-
The Use of Transdermal Fentanyl (FEN) Versus Morphine (MOR) in Cancer Pain Patients in IsraelNuyts, G. D. / Fridman, N. / De Cooman, F. et al. | 2000
- 355
-
Management of Lung Cancer in FranceSchmitt, C. / Vergnenegre, A. / Schuller-Lebeau, M. P. / Frappe, M. / Bouin, O. et al. | 2000
- 355
-
A Methodology for Implementing Quality-Adjusted Disease Free Survival (QADFS) with Multidimensional Quality of Life (QoL) Instruments in Cancer TrialsSingh, A. / Padley, R. J. / Ashraf, T. et al. | 2000
- 356
-
Development and Preliminary Psychometric Validation of the Patient Assessment of Upper Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) in GI PatientsRentz, A. / Schmier, A. / de la Loge, C. / Dubois, D. / Jones, R. / Peeters, K. / Zodet, M. / Revicki, D. et al. | 2000
- 356
-
Is Health-Related Quality of Life (HRQL) Improved by Gastro-Esophageal Reflux Disease (GERD) Drugs?Chassany, O. / Duracinsky, M. / Bergmann, J. F. et al. | 2000
- 357
-
The Burden of Illness of Irritable Bowel Syndrome (IBS) Using the Rome II CriteriaBadia, X. / Mearin, F. / Balboa, A. / Baro, E. / Caldwell, E. / Cucala, M. / Diaz-Rubio, M. / Fueyo, A. / Ponce, J. / Roset, M. et al. | 2000
- 357
-
Decision Analysis of Omeprazole Versus Laparoscopic Nissen Fundoplication for Treating Patients with Severe Gastroesophageal Reflux DiseaseCantrell, C. R. / Wilde, S. W. / Martin, B. C. et al. | 2000
- 357
-
Utilization and Costs of Gastrointestinal Drugs in Relation to Helicobacter-pylori Eradication; Pharmacoeconomic Analysis for The NetherlandsPostma, M. J. / Van den Berg, P. B. / Klok, R. M. / Brouwers, J. R. / De Jong-van den Berg, L. T. et al. | 2000
- 358
-
In Finland, Sweden and the UK, Esomeprazole is Cost-Effective Compared with Omeprazole for the Acute Treatment of Patients with Reflux OesophagitisWahlqvist, P. et al. | 2000
- 358
-
Development and Initial Psychometric Validation of the Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life Instrument (PAGI-QOL) in GI Patientsde la Loge, C. / Rentz, A. / Dubois, D. / Jones, R. / Peeters, K. / Marquis, P. et al. | 2000
- 359
-
Evaluation of the Direct Cost of Care for Patients Suffering from HemorrhoidsTaieb, C. / Smadja, C. et al. | 2000
- 359
-
Analysis of the Direct Cost Generated by Infliximab to Normalize Quality of Life in Patients with Crohn's DiseaseAnnemans, L. / Lemmens, L. / Noman, M. / Cornellie, F. / Nijns, V. / Quataert, M. / Goossens, A. / Rutgeerts, P. et al. | 2000
- 359
-
Irritable Bowel Syndrome (IBS) in Germany: A Cost of Illness StudyPirk, O. / Fricke, F. U. / Spannheimer, A. / Reitberger, U. / Schultes, H. J. / Muller-Lissner, S. et al. | 2000
- 360
-
Development and Preliminary Psychometric Validation of the Patient Assessment of Upper Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) in GastroparesisSchmier, J. / Rentz, A. / de la Loge, C. / Dubois, D. / Jones, R. / Peeters, K. / Revicki, D. et al. | 2000
- 360
-
In Finland, Sweden and the UK, on Demand Treatment with Esomeprazole is Cost-Effective in Patients with Gord Without OesophagitisWahlqvist, P. et al. | 2000
- 360
-
Esomeprazole is Cost-Effective Compared with Omeprazole for the Acute Treatment of Patients with Non-Endoscoped Gord in the UKWahlqvist, P. / Higgins, A. / Green, J. et al. | 2000
- 361
-
Adapting a US Cost-Offset Economic Model for Overactive Bladder for the European MarketplaceBentkover, J. D. / Chapple, C. / Corey, R. / Hill, S. / Stewart, E. J. et al. | 2000
- 361
-
Modelling of an Antiobesity Treatment: Cost-Effectiveness Model in the UKKnight, C. / Ratcliffe, A. / Howard, P. / Snee, N. / Farina, C. et al. | 2000
- 361
-
Costs and Resources Associated with the Treatment of Overactive Bladder Using Retrospective Medical Care Claims DataWilliamson, T. / Hall, J. / Nelson, M. / Meyer, J. et al. | 2000
- 362
-
Prevalence of Bladder Control Problems in a Large German Population SampleGoepel, M. et al. | 2000
- 362
-
Cost-Effectiveness and Cost-Utility Analysis of Interferon Beta-1b in Relapsing-Remitting Multiple Sclerosis in Poland (2-Years Perspective)Orlewska, E. / Mierzejewski, P. / Czlonkowska, A. et al. | 2000
- 362
-
Factors Associated with Selecting Medication to Treat Patients Newly Diagnosed with Overactive BladderLenderking, W. R. / Grossman, M. / Bull, S. et al. | 2000
- 363
-
A Cost Minimization Model for 2:1 Therapeutic Interchange Protocols of Medications with Highly Variable Dosing RegimensGordon, M. et al. | 2000
- 363
-
The Role of Cognitive Methods in the Design of Conjoint Analysis to Evaluate Epilepsy TreatmentsMansfield, C. / Fehnel, S. / Deal, L. / Kearney, M. et al. | 2000
- 364
-
Subjective and Objective Quality of Life Change Scores in a Short-Term Epilepsy StudyAbetz, L. N. / Graham, L. A. et al. | 2000
- 364
-
The Long-Term Economic Impact of Treating Alzheimer's Patients in Sweden with GalantamineGarfield, F. B. / Getsios, D. / Mehnert, A. / Wallin, A. / AHEAD Study Group et al. | 2000
- 364
-
A Stochastic Cost-Effectiveness Analysis of Alternative Acute Treatment Strategies for Migraine: The Disability in Strategies for Care (DISC) StudySculpher, M. J. / Millson, D. / Poole, L. et al. | 2000
- 365
-
A Canadian Adaptation of a Decision Analytic Model for the Economic Evaluation of Opioids for Chronic PainNeighbors, D. M. / Lopez, R. / Ingham, M. / Bell, T. J. et al. | 2000
- 365
-
Cost-Effectiveness Analysis of Entacapone in Advanced Parkinson's Disease a Markov Process AnalysisNuijten, M. C. / van Iperen, H. P. / Snyder, E. / Palmer, C. et al. | 2000
- 366
-
Health-Related Quality of Life Among French Patients Hospitalized in Internal MedicineChassany, O. / Desfosses, C. / Gatfosse, J. M. / Leplege, A. / Caulin, C. et al. | 2000
- 366
-
General Population-Based Quality of Life Measurements Using the EQ-5D QuestionnaireSzende, A. / Molnar, L. et al. | 2000
- 366
-
Change and Status in Quality of Life (CaSinQoL) in Northern Sweden in 1997/98: by Declared Regularity of Pharmaceutical Drug IntakeKempe, A. / Hyttsten, R. / Hornquist, J. O. et al. | 2000
- 367
-
Change and Status in Quality of Life (CaSinQoL) in Northern Sweden in 1997/98: Psychometrics of the Mini QLcs Assessment Battery AppliedHornquist, J. O. / Hansson, B. / Hornquist, A. et al. | 2000
- 367
-
Monetary Value of Quality of Life ImprovementsLachaine, J. / Laurier, C. / Contandriopoulos, A. P. et al. | 2000
- 368
-
The Use of Surrogate Endpoint Data in Evaluating Treatment Efficacy: Impact on Decision-Making and Expenditure within the Australian Pharmaceutical Benefits SchemeLopert, R. / Hill, S. R. / Henry, D. A. et al. | 2000
- 368
-
Nice Requirements for Cost-Effectiveness Evidence: Potential Sample Size Implications of Generating Trial-Based EvidenceBackhouse, M. E. / Gaffney, L. / Mauskopf, J. A. et al. | 2000
- 369
-
Differing Levels of Patient Satisfaction with Pharmacy Services in a Managed Care OrganizationFincham, J. E. et al. | 2000
- 369
-
Temporal Trends and Ethnic Variations in Amenable Mortality in Singapore from 1965 to 1994: The Impact of Health Care in TransitionNiti, M. / Ng, P. et al. | 2000
- 370
-
International Comparison of Pharmacoeconomic Guidelines: Consensus, Divergence and Practical ImplicationsBaron, F. / Marquis, P. / Evans, C. / Crawford, B. et al. | 2000
- 370
-
Do Decision-Makers Find Economic Evaluations Useful? Results of Focus Group Research in the UKDrummond, M. F. / Stoykova, B. / Nixon, J. / Hoffman, C. / Glanville, J. et al. | 2000
- 370
-
An Economic Evaluation of Pharmaceutical Cost Containment Policies in Alberta, CanadaFassbender, K. / Pickard, A. S. et al. | 2000
- 371
-
Atlas of Avoidable Deaths in ItalyBamfi, F. / Arpinelli, F. / Mannino, S. / Nicolosi, A. et al. | 2000
- 371
-
Reimbursed Drug Regulation: Comparing Two Models for Control Drugs Consumption in Israel Using Permeation Coefficient ParameterKlang, S. / Liebermann, N. / Porath, A. / Peterburg, I. et al. | 2000
- 372
-
Willingness to Pay for Avoiding Adverse Effects of DrugsRodriguez, R. / Rovira, J. et al. | 2000
- 372
-
Consumer Use of the Internet for Healthcare InformationDonohue, J. A. et al. | 2000
- 372
-
The French Health Utilities Index Mark 3Le Gales, C. / Buron, C. / Costet, N. / Rosman, S. / Slama, G. et al. | 2000
- 373
-
Guiding Principles to Compare the Efficacy of Novel Drugs Using RCT Matched Arm ComparisonsLaer, C. / LeLorier, J. et al. | 2000
- 373
-
Power and Sample Size Calculations for a Clinical Trial Considering Cost-Effectiveness and Statistical ErrorsKamae, I. / Yanagisawa, S. et al. | 2000
- 373
-
The Influence of Non-Compliance on the Effectiveness and Cost-Effectiveness of Drug TherapiesHughes, D. / Bagust, A. / Haycox, A. / Walley, T. et al. | 2000
- 374
-
Projecting Economic Results of a European Trial to the United States: Issues and MethodsSorensen, S. / de Lissovoy, G. / Mathur, S. / Duttagupta, S. et al. | 2000
- 374
-
Societal Impact of Lost Earnings Associated with Age-Related MaculopathyHua, K. / Cockrum, P. / Von Tress, M. / Barnes, R. et al. | 2000
- 374
-
Measurements of Health Status in DenmarkWittrup-Jensen, K. U. / Brooks, R. / Gudex, C. / Pedersen, K. M. et al. | 2000
- 375
-
The Cost of Glaucoma Treatment in Poland-Results from Observational StudyOrlewska, E. / Czechowicz-Janicka, K. / Tobota, Z. et al. | 2000
- 375
-
Cost-Effectiveness Analysis of Continous Terbinafine vs Intermittent Itraconazole in the Treatment of Toenail Onychomycosis in PolandOrlewska, E. et al. | 2000
- 376
-
Cost-Effectiveness of Brinzolamide versus Dorzolamide in the Treatment of Ocular Hypertension and Primary Open Angle GlaucomaGouveia Pinto, C. / Le Pen, C. / Rumeau-Pichon, C. / Berto, P. / Berdeaux, G. et al. | 2000
- 376
-
Pharmacoeconomic Evaluation of Calcipotriol and UVB in the Treatment of Psoriasis in The Netherlandsde Rie, M. A. / de Hoop, D. / Jonsson, L. / Bakkers, E. J. / Sorensen, M. et al. | 2000
- 377
-
Evaluation of the Validity of Retrospective QoL OutcomesKrabbe, P. F. / Hinderink, J. B. / van de Broek, P. et al. | 2000